These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 37781182)

  • 21. Case Series of Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis With Nivolumab and Nivolumab/ Ipilimumab Combination Therapy in Metastatic Melanoma.
    Lee O; Masood M; Nutan F
    J Drugs Dermatol; 2022 May; 21(5):529-530. PubMed ID: 35533039
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Case Report: Stevens-Johnson Syndrome and Hepatotoxicity Induced by Osimertinib Sequential to Pembrolizumab in a Patient With EGFR-Mutated Lung Adenocarcinoma.
    Gianni C; Bronte G; Delmonte A; Burgio MA; Andrikou K; Monti M; Menna C; Frassineti GL; Crinò L
    Front Pharmacol; 2021; 12():672233. PubMed ID: 34456717
    [No Abstract]   [Full Text] [Related]  

  • 23. Lichenoid dermatitis following PD-1 inhibitor-induced toxic epidermal necrolysis: a case report and literature review.
    Zhang L; Wang L; Cheng Q; Lei X; Wu J; Chen N
    Immunotherapy; 2023 Oct; 15(15):1249-1256. PubMed ID: 37585673
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Neutrophils initiate and exacerbate Stevens-Johnson syndrome and toxic epidermal necrolysis.
    Kinoshita M; Ogawa Y; Hama N; Ujiie I; Hasegawa A; Nakajima S; Nomura T; Adachi J; Sato T; Koizumi S; Shimada S; Fujita Y; Takahashi H; Mizukawa Y; Tomonaga T; Nagao K; Abe R; Kawamura T
    Sci Transl Med; 2021 Jun; 13(600):. PubMed ID: 34193610
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Stevens-Johnson syndrome/toxic epidermal necrolysis mouse model generated by using PBMCs and the skin of patients.
    Saito N; Yoshioka N; Abe R; Qiao H; Fujita Y; Hoshina D; Suto A; Kase S; Kitaichi N; Ozaki M; Shimizu H
    J Allergy Clin Immunol; 2013 Feb; 131(2):434-41.e1-9. PubMed ID: 23111236
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pembrolizumab-Associated Stevens-Johnson Syndrome in a Patient With Metastatic Non-small Cell Lung Cancer: A Case Report.
    Sandhu M; Kc B; Bhandari J; Gambhir HS; Farah R
    Cureus; 2023 Jul; 15(7):e41439. PubMed ID: 37546048
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Allopurinol-Induced Stevens-Johnson Syndrome.
    Gupta SS; Sabharwal N; Patti R; Kupfer Y
    Am J Med Sci; 2019 Apr; 357(4):348-351. PubMed ID: 30638600
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Stevens-Johnson syndrome and concurrent hand foot syndrome during treatment with capecitabine: A case report.
    Ahn HR; Lee SK; Youn HJ; Yun SK; Lee IJ
    World J Clin Cases; 2021 Jun; 9(17):4279-4284. PubMed ID: 34141791
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cutaneous Adverse Events of Immune Checkpoint Inhibitors: A Summarized Overview.
    Plachouri KM; Vryzaki E; Georgiou S
    Curr Drug Saf; 2019; 14(1):14-20. PubMed ID: 30058498
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Acute generalized exanthematous pustulosis and Stevens-Johnson syndrome overlap due to hydroxychloroquine: a case report.
    Coleman I; Ruiz G; Brahmbhatt S; Ackerman L
    J Med Case Rep; 2020 Nov; 14(1):210. PubMed ID: 33138853
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A case report involving suppressed nuclear receptor transcription factors 4a1 and Stevens-Johnson syndrome induced by a single dose of pembrolizumab and successfully treated with early steroid administration, resulting in complete remission of stage III lung cancer.
    Machida M; Yamazaki C; Kouda N; Hanai Y; Sato H; Konda A; Yamagata Y; Itho T; Aisaka H
    J Pharm Health Care Sci; 2022 Dec; 8(1):29. PubMed ID: 36464708
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Lichenoid mucocutaneous reactions associated with sintilimab therapy in a non-small cell lung adenocarcinoma patient: case report and review.
    Zhou S; Zhang Z; Feng X; Zhao C; Jiang L
    Front Pharmacol; 2023; 14():1276788. PubMed ID: 38161699
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Stevens-Johnson syndrome induced by paclitaxel in a patient with squamous cell carcinoma of the lung: a case report.
    Hiraki A; Aoe K; Murakami T; Maeda T; Eda R; Takeyama H
    Anticancer Res; 2004; 24(2C):1135-7. PubMed ID: 15154637
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Interim analysis of the efficiency and safety of neoadjuvant PD-1 inhibitor (sintilimab) combined with chemotherapy (nab-paclitaxel and carboplatin) in potentially resectable stage IIIA/IIIB non-small cell lung cancer: a single-arm, phase 2 trial.
    Sun C; Liu Y; Zhang P; Wang X; Xu Y; Lin X; Ma X; Guo Y; Qiu S; Shao G; Yang Z; Ma K
    J Cancer Res Clin Oncol; 2023 Feb; 149(2):819-831. PubMed ID: 35192053
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Stevens-Johnson syndrome precipitated by Moderna Inc. COVID-19 vaccine: a case-based review of literature comparing vaccine and drug-induced Stevens-Johnson syndrome/toxic epidermal necrolysis.
    Padniewski JJ; Jacobson-Dunlop E; Albadri S; Hylwa S
    Int J Dermatol; 2022 Aug; 61(8):923-929. PubMed ID: 35398905
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Recurrent Stevens-Johnson syndrome in a patient with systemic lupus erythematosus: a case report.
    Ahmed Eltahir NI; Elgenaid SN; Adam Essa ME; Ahmed AA; Sati Mohamed AS; Ali Hussein MM; Abubaker A; Mohamed Elsayed E; Mohammed Ibrahim SE; Mohamed Ibrahim O; Mohammed Elagib E
    J Int Med Res; 2020 Oct; 48(10):300060520964348. PubMed ID: 33086898
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Attenuation of Wnt/β-catenin signaling in patients with Stevens-Johnson syndrome and toxic epidermal necrolysis.
    Chen CB; Chang WC; Wu MY; Kao TY; Wang YW; Wang CW; Chen CJ; Chung WH; Su SC
    Int J Biol Sci; 2020; 16(2):353-364. PubMed ID: 31929762
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Stevens-Johnson syndrome/toxic epidermal necrolysis successfully treated with Chinese herbal medicine Pi-Yan-Ning: A case report.
    Chen SY; Chen QW; Shou LM; Pan H; Ruan SM; Liang ZH; Shu QJ
    J Integr Med; 2021 Nov; 19(6):555-560. PubMed ID: 34696996
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Stevens-Johnson Syndrome Associated With Chlordiazepoxide.
    Jawaro T; Kumar A; Pistun O; Dixit D
    J Pharm Technol; 2018 Apr; 34(2):82-85. PubMed ID: 34860942
    [No Abstract]   [Full Text] [Related]  

  • 40. Possible lenalidomide-induced Stevens-Johnson syndrome during treatment for multiple myeloma.
    Boruah PK; Bolesta S; Shetty SM
    Pharmacotherapy; 2011 Sep; 31(9):925. PubMed ID: 21923596
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.